+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
FEMALE
ID06659120

Observational Study of Fremanezumab to Prevent Menstrual-Related Migraine Attacks in Premenopausal Women

Led by Insel Gruppe AG, University Hospital Bern · Updated on 2024-10-26

120

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how the drug fremanezumab affects menstrual migraine attacks compared to non-menstrual migraine attacks in real-world clinical practice. This observational study focuses on premenopausal women diagnosed with episodic or chronic migraine who experience menstrually-related migraine, with or without aura. The main goal is to find out if menstrual migraine attacks respond as well to fremanezumab as other migraine attacks. Patients are treated according to routine care and criteria for anti-CGRP mAb treatment in Switzerland. Participants will receive fremanezumab treatment following standard medical guidelines, with no additional study-specific interventions. Women included are those with a regular menstrual cycle and a history of migraines for at least one year, having at least eight migraine days per month and at least two days of menstrually-related migraine per cycle. The study requires maintaining a detailed headache diary for at least three months before starting fremanezumab and six months after treatment initiation. During the study, participants will keep a daily headache diary recording headache details, medication use, menstrual bleeding, and symptoms related to endometriosis if present. Researchers will measure changes in the number of migraine days per month over six months, as well as changes in disability, quality of life, anxiety, depression, fatigue, and hormonal treatment use. The study is observational, with no experimental treatments beyond routine care, and will last at least six months from the start of fremanezumab treatment.

CONDITIONS

Brief Title

Fremanezumab for the Prevention of Menstrually-related Migraine Attacks

Research Team

C

Christoph J Schankin, Prof

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here